Philips Respironics Recall Notice:
Philips Respironics issued a Recall Notification for some CPAP and BiLevel PAP devices and mechanical ventilators due to potential health risks related to foam used in the devices. To learn more, visit the Philips Website and review FDA’s Safety Communication and FAQs. For questions about the Philips recall, please contact Philips at 1-877-907-7508.
Pulmonary Arterial Hypertension (PAH) is a rare, but serious condition that affects the arteries in the lungs and eventually leads to right-sided heart failure. It is a progressive illness, meaning it can worsen over time, and can sometimes even be fatal. There is no known cure for PAH, but treatment can control symptoms, prevent further lung and heart damage, and greatly improve the quality of life for patients living with the condition.
Due to the complexity of the condition, Northside Hospital has developed a dedicated program specifically designed for the diagnosis and treatment of PAH. Northside has a designated in-patient nursing care team and unit to care for PAH patients. Our expert
team of board-certified pulmonologists, physical
assistants and mid-level providers have years of experience dealing with PAH and work together to provide patients the highest level of care possible.
Northside Hospital’s Pulmonary Hypertension Program offers the most effective treatments for both mild and severe PAH cases, including but not limited to:
Research studies are available.